BCL2 and breast carcinoma: A multivariate analysis incorporating five published studies from 11,212 breast cancer cases strongly supported the independent prognostic significance of BCL2 positivity with improved survival (Hazard Ratio (HR) 0.76, 95% Confidence Interval (CI) 0.54-0.74), p <0.001)(Dawson et al. 2010).